JP6659541B2 - 体液中の分析物の濃度を決定する方法及び装置 - Google Patents
体液中の分析物の濃度を決定する方法及び装置 Download PDFInfo
- Publication number
- JP6659541B2 JP6659541B2 JP2016535087A JP2016535087A JP6659541B2 JP 6659541 B2 JP6659541 B2 JP 6659541B2 JP 2016535087 A JP2016535087 A JP 2016535087A JP 2016535087 A JP2016535087 A JP 2016535087A JP 6659541 B2 JP6659541 B2 JP 6659541B2
- Authority
- JP
- Japan
- Prior art keywords
- detector
- demodulated
- test carrier
- light source
- analyzer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title claims description 232
- 239000012491 analyte Substances 0.000 title claims description 97
- 210000001124 body fluid Anatomy 0.000 title claims description 81
- 239000010839 body fluid Substances 0.000 title claims description 32
- 238000012360 testing method Methods 0.000 claims description 316
- 238000001514 detection method Methods 0.000 claims description 162
- 230000001771 impaired effect Effects 0.000 claims description 31
- 238000004458 analytical method Methods 0.000 claims description 30
- 238000011156 evaluation Methods 0.000 claims description 30
- 230000006735 deficit Effects 0.000 claims description 14
- 238000001914 filtration Methods 0.000 claims description 13
- 238000012795 verification Methods 0.000 claims description 10
- 238000005259 measurement Methods 0.000 description 101
- 239000000126 substance Substances 0.000 description 54
- 239000000758 substrate Substances 0.000 description 26
- 238000006243 chemical reaction Methods 0.000 description 25
- 238000004422 calculation algorithm Methods 0.000 description 24
- 239000010410 layer Substances 0.000 description 17
- 230000003287 optical effect Effects 0.000 description 17
- 230000008859 change Effects 0.000 description 16
- 230000006870 function Effects 0.000 description 14
- 238000004590 computer program Methods 0.000 description 13
- 238000012545 processing Methods 0.000 description 13
- 238000005375 photometry Methods 0.000 description 12
- 230000008569 process Effects 0.000 description 11
- 230000005540 biological transmission Effects 0.000 description 9
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 8
- 239000000969 carrier Substances 0.000 description 8
- 150000001875 compounds Chemical class 0.000 description 8
- 239000008103 glucose Substances 0.000 description 8
- 239000012530 fluid Substances 0.000 description 7
- 230000000737 periodic effect Effects 0.000 description 7
- 230000003595 spectral effect Effects 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 238000012544 monitoring process Methods 0.000 description 5
- -1 Vol. 10 Substances 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 238000003780 insertion Methods 0.000 description 4
- 230000037431 insertion Effects 0.000 description 4
- 239000000049 pigment Substances 0.000 description 4
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000014509 gene expression Effects 0.000 description 3
- 238000005286 illumination Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000015654 memory Effects 0.000 description 3
- 238000007781 pre-processing Methods 0.000 description 3
- 238000011002 quantification Methods 0.000 description 3
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 2
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 238000012935 Averaging Methods 0.000 description 2
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 2
- 102000004420 Creatine Kinase Human genes 0.000 description 2
- 108010042126 Creatine kinase Proteins 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000005534 hematocrit Methods 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- 230000001788 irregular Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000002356 single layer Substances 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108010023302 HDL Cholesterol Proteins 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 108010028554 LDL Cholesterol Proteins 0.000 description 1
- 238000008214 LDL Cholesterol Methods 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 101710098398 Probable alanine aminotransferase, mitochondrial Proteins 0.000 description 1
- 102000003929 Transaminases Human genes 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 229910010293 ceramic material Inorganic materials 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 229940109239 creatinine Drugs 0.000 description 1
- 238000013500 data storage Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 210000003722 extracellular fluid Anatomy 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 239000001023 inorganic pigment Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001902 propagating effect Effects 0.000 description 1
- 238000002310 reflectometry Methods 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 229940045136 urea Drugs 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 238000001429 visible spectrum Methods 0.000 description 1
- 230000003936 working memory Effects 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/84—Systems specially adapted for particular applications
- G01N21/8483—Investigating reagent band
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01J—MEASUREMENT OF INTENSITY, VELOCITY, SPECTRAL CONTENT, POLARISATION, PHASE OR PULSE CHARACTERISTICS OF INFRARED, VISIBLE OR ULTRAVIOLET LIGHT; COLORIMETRY; RADIATION PYROMETRY
- G01J3/00—Spectrometry; Spectrophotometry; Monochromators; Measuring colours
- G01J3/28—Investigating the spectrum
- G01J3/42—Absorption spectrometry; Double beam spectrometry; Flicker spectrometry; Reflection spectrometry
- G01J3/433—Modulation spectrometry; Derivative spectrometry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
- G01N21/77—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator
- G01N21/78—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator producing a change of colour
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/48707—Physical analysis of biological material of liquid biological material by electrical means
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
- G01N21/77—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator
- G01N2021/7769—Measurement method of reaction-produced change in sensor
- G01N2021/7786—Fluorescence
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
- G01N21/27—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands using photo-electric detection ; circuits for computing concentration
- G01N21/274—Calibration, base line adjustment, drift correction
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/47—Scattering, i.e. diffuse reflection
- G01N21/4738—Diffuse reflection, e.g. also for testing fluids, fibrous materials
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2201/00—Features of devices classified in G01N21/00
- G01N2201/06—Illumination; Optics
- G01N2201/061—Sources
- G01N2201/06113—Coherent sources; lasers
- G01N2201/0612—Laser diodes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2201/00—Features of devices classified in G01N21/00
- G01N2201/06—Illumination; Optics
- G01N2201/062—LED's
- G01N2201/0621—Supply
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2201/00—Features of devices classified in G01N21/00
- G01N2201/06—Illumination; Optics
- G01N2201/069—Supply of sources
- G01N2201/0696—Pulsed
- G01N2201/0697—Pulsed lasers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/4875—Details of handling test elements, e.g. dispensing or storage, not specific to a particular test method
Landscapes
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Physics & Mathematics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Food Science & Technology (AREA)
- Biophysics (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Urology & Nephrology (AREA)
- Plasma & Fusion (AREA)
- Medicinal Chemistry (AREA)
- Optics & Photonics (AREA)
- Mathematical Physics (AREA)
- Theoretical Computer Science (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13194791.3 | 2013-11-28 | ||
| EP13194791 | 2013-11-28 | ||
| PCT/EP2014/075780 WO2015078954A1 (en) | 2013-11-28 | 2014-11-27 | Method and device for determining a concentration of an analyte in a bodily fluid |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019197530A Division JP2020024219A (ja) | 2013-11-28 | 2019-10-30 | 体液中の分析物の濃度を決定する方法及び装置 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017501395A JP2017501395A (ja) | 2017-01-12 |
| JP2017501395A5 JP2017501395A5 (enExample) | 2017-12-21 |
| JP6659541B2 true JP6659541B2 (ja) | 2020-03-04 |
Family
ID=49679379
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016535087A Active JP6659541B2 (ja) | 2013-11-28 | 2014-11-27 | 体液中の分析物の濃度を決定する方法及び装置 |
| JP2019197530A Ceased JP2020024219A (ja) | 2013-11-28 | 2019-10-30 | 体液中の分析物の濃度を決定する方法及び装置 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019197530A Ceased JP2020024219A (ja) | 2013-11-28 | 2019-10-30 | 体液中の分析物の濃度を決定する方法及び装置 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US10274430B2 (enExample) |
| EP (1) | EP3074758B1 (enExample) |
| JP (2) | JP6659541B2 (enExample) |
| KR (1) | KR102245011B1 (enExample) |
| CN (2) | CN110261379B (enExample) |
| CA (1) | CA2926287C (enExample) |
| WO (1) | WO2015078954A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3591385A1 (en) | 2018-07-06 | 2020-01-08 | Roche Diabetes Care GmbH | A detection method for detecting an analyte in a sample |
| WO2020152510A1 (en) * | 2019-01-25 | 2020-07-30 | Matai Laxman | Hemoglobin analyzer |
| US20240094134A1 (en) * | 2021-01-13 | 2024-03-21 | Hitachi High-Tech Corporation | Automatic analyzer and automatic analysis method |
| CN113655011B (zh) * | 2021-10-20 | 2022-02-08 | 武汉新烽光电股份有限公司 | 一种微流控检测系统及其检测方法 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2934190A1 (de) * | 1979-08-23 | 1981-03-19 | Müller, Gerhard, Prof. Dr.-Ing., 7080 Aalen | Verfahren und vorrichtung zur molekuelspektroskopie, insbesondere zur bestimmung von stoffwechselprodukten |
| JP3046610B2 (ja) * | 1990-04-24 | 2000-05-29 | 松下電工株式会社 | 粉塵検出装置 |
| DE4041905A1 (de) * | 1990-12-27 | 1992-07-02 | Boehringer Mannheim Gmbh | Testtraeger-analysesystem |
| US5526120A (en) * | 1994-09-08 | 1996-06-11 | Lifescan, Inc. | Test strip with an asymmetrical end insuring correct insertion for measuring |
| IL121279A (en) * | 1996-07-16 | 2001-05-20 | Roche Diagnostics Gmbh | An analytical system with means for testing samples with too small volumes |
| DE19706520A1 (de) * | 1997-02-19 | 1998-08-20 | Lre Technology Partner Gmbh | Meßgerät zur Bestimmung der Konzentration mindestens einer Substanz in einer Körperflüssigkeit, insbesondere Blutzuckermeßgerät |
| CN1131425C (zh) | 1997-10-31 | 2003-12-17 | 技术化学品及产品股份有限公司 | 反射计 |
| DE10061336A1 (de) * | 2000-12-08 | 2002-06-13 | Roche Diagnostics Gmbh | System zur Analyse von Probeflüssigkeiten beinhaltend eine Lagekontrolleinheit |
| CA2366802A1 (en) * | 2001-01-17 | 2002-07-17 | Bayer Corporation | Method and apparatus for using infrared readings to detect misidentification of a diagnostic test strip in a reflectance spectrometer |
| US20030169426A1 (en) * | 2002-03-08 | 2003-09-11 | Peterson Timothy A. | Test member orientation |
| US20080119421A1 (en) * | 2003-10-31 | 2008-05-22 | Jack Tuszynski | Process for treating a biological organism |
| CN100496395C (zh) * | 2004-05-06 | 2009-06-10 | 日本电信电话株式会社 | 成分浓度测定装置和成分浓度测定装置控制方法 |
| GB0416732D0 (en) * | 2004-07-27 | 2004-09-01 | Precisense As | A method and apparatus for measuring the phase shift induced in a light signal by a sample |
| EP1801568A1 (de) * | 2005-12-21 | 2007-06-27 | Micronas Holding GmbH | Teststreifen und Verfahren zum Messen einer Analytkonzentration in einer Probe eines biologischen Fluids |
| ATE491935T1 (de) * | 2006-10-14 | 2011-01-15 | Hoffmann La Roche | Anordnung und verfahren zum erfassen und auswerten optischer signale |
| US20100187450A1 (en) * | 2007-06-21 | 2010-07-29 | Koninklijke Philips Electronics N.V. | Microelectronic sensor device with light source and light detector |
| JP2012524277A (ja) * | 2009-04-15 | 2012-10-11 | レリア ダイアグノスティック システムズ,インク. | 試験ストリップのダイナミックレンジの拡張 |
| CN101813618A (zh) * | 2010-01-07 | 2010-08-25 | 中国科学院半导体研究所 | 基于光声效应的多种气体同时检测装置及检测方法 |
| EP2362207A1 (de) * | 2010-01-28 | 2011-08-31 | F. Hoffmann-La Roche AG | Messsystem und Messverfahren insbesondere zur Blutzuckerbestimmung |
| ITMI20101730A1 (it) * | 2010-09-23 | 2012-03-24 | Fond Italiana Fegato Onlus | Sistema di tipo "point of care" di misura della bilirubina totale nel plasma, in particolare di neonati |
| DE102011118607A1 (de) * | 2011-09-14 | 2013-03-14 | Friedrich-Schiller-Universität Jena | Verfahren und Anordnung zur Streulichtmessung |
-
2014
- 2014-11-27 WO PCT/EP2014/075780 patent/WO2015078954A1/en not_active Ceased
- 2014-11-27 EP EP14808560.8A patent/EP3074758B1/en active Active
- 2014-11-27 KR KR1020167013056A patent/KR102245011B1/ko active Active
- 2014-11-27 JP JP2016535087A patent/JP6659541B2/ja active Active
- 2014-11-27 CN CN201910384611.3A patent/CN110261379B/zh active Active
- 2014-11-27 CA CA2926287A patent/CA2926287C/en active Active
- 2014-11-27 CN CN201480065071.8A patent/CN105992945A/zh active Pending
-
2016
- 2016-05-04 US US15/145,840 patent/US10274430B2/en active Active
-
2019
- 2019-10-30 JP JP2019197530A patent/JP2020024219A/ja not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| KR20160091897A (ko) | 2016-08-03 |
| CN110261379A (zh) | 2019-09-20 |
| EP3074758B1 (en) | 2019-02-27 |
| CA2926287C (en) | 2020-03-24 |
| US20160245755A1 (en) | 2016-08-25 |
| JP2020024219A (ja) | 2020-02-13 |
| US10274430B2 (en) | 2019-04-30 |
| KR102245011B1 (ko) | 2021-04-27 |
| CA2926287A1 (en) | 2015-06-04 |
| WO2015078954A1 (en) | 2015-06-04 |
| JP2017501395A (ja) | 2017-01-12 |
| CN105992945A (zh) | 2016-10-05 |
| CN110261379B (zh) | 2021-11-12 |
| EP3074758A1 (en) | 2016-10-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020024219A (ja) | 体液中の分析物の濃度を決定する方法及び装置 | |
| RU2400733C2 (ru) | Система для спектроскопии пропускания для использования при определении анализируемых веществ в жидкости организма | |
| US7390665B2 (en) | Distinguishing test types through spectral analysis | |
| JP5159760B2 (ja) | ヒストグラムを用いる光学データの解析 | |
| US6525330B2 (en) | Method of strip insertion detection | |
| JP6521948B2 (ja) | 体液中の分析物を検出するための方法およびシステム | |
| CA2597295C (en) | Method for analyzing a sample on a test element and analysis system | |
| JP2005513498A (ja) | 試料・検体とは無関係の光強度変化を考慮して検体濃度を決定するための分析システム | |
| WO2013149598A1 (en) | Test strips and method for reading test strips | |
| EP2941630A1 (en) | Test strips and method for reading test strips | |
| JP2010261944A (ja) | 光学測定キュベットの汚染物質の検出方法 | |
| WO2014096184A1 (en) | Method for analyzing a sample of a body fluid | |
| US20250155428A1 (en) | Systems and methods of optically determining analyte concentrations | |
| US7630084B2 (en) | System and method for acquiring and evaluating optical signals | |
| CN101490531B (zh) | 控制液的自动判别方法 | |
| HK40014414A (en) | Method and device for determining a concentration of an analyte in a bodily fluid | |
| HK1229427A1 (en) | Method and device for determining a concentration of an analyte in a bodily fluid | |
| HK40014414B (zh) | 用於确定体液中的分析物的浓度的方法和设备 | |
| JP7385649B2 (ja) | 体液サンプル中の分析物濃度を測定するための装置および方法 | |
| EP4286834A1 (en) | Component measurement device, component measurement device set, and information processing method | |
| HK40050710A (en) | Devices and method for measuring an analyte concentration in a sample of bodily fluid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20171109 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20171109 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20180914 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20181016 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20190116 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20190702 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20191030 |
|
| A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20191106 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20200107 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20200206 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 6659541 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |